 |
|
Effect of Discontinuing Aspirin Therapy on the Risk of Brain Ischemic Stroke
Alexandre Balzano Maulaz, MD;
Daniel C. Bezerra, MD;
Patrik Michel, MD;
Julien Bogousslavsky, MD
Arch Neurol. 2005;62:1217-1220.
Background Aspirin, or acetylsalicylic acid, is widely used to prevent ischemic vascular disease. Clinical and experimental data suggest that a rebound effect occurs 4 or fewer weeks after interruption of aspirin therapy.
Objective To study the discontinuation of aspirin therapy as a risk factor for ischemic stroke (IS).
Design Case-control study.
Setting Stroke unit.
Participants Three hundred nine patients with IS or transient ischemic attack undergoing long-term aspirin treatment before their index event and 309 age-, sex-, and antiplatelet therapy–matched controls who had not had an IS in the previous 6 months.
Methods We compared the frequency of aspirin therapy discontinuation during the 4 weeks before an ischemic cerebral event in patients and the 4 weeks before interview in controls.
Results The 2 groups had a similar frequency of risk factors, except for coronary heart disease, which was more frequent in patients (36% vs 18%; P<.001). Aspirin use had been discontinued in 13 patients and 4 controls. Aspirin interruption yielded an odds ratio for IS/transient ischemic attack of 3.4 (95% confidence interval, 1.08-10.63; P<.005) after adjustment in a multivariable model.
Conclusions These results highlight the importance of aspirin therapy compliance and give an estimate of the risk associated with the discontinuation of aspirin therapy in patients at risk for IS, particularly those with coronary heart disease.
Author Affiliations: Department of Neurology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
RELATED LETTERS
Rebound Inflammation and the Risk of Ischemic Stroke After Discontinuation of Aspirin Therapy
Michal R. Pijak
Arch Neurol. 2006;63(2):300-301.
EXTRACT
| FULL TEXT
Rebound Inflammation and the Risk of Ischemic Stroke After Discontinuation of Aspirin Therapy—Reply
Alexandre B. Maulaz, Daniel C. Bezerra, Patrik Michel, and Julien Bogousslavsky
Arch Neurol. 2006;63(2):301.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Adverse Events Associated With Stopping Clopidogrel After Acute Coronary Syndrome
Goyal and Punnam
JAMA 2008;299:2389-2389.
FULL TEXT
Incidence of Death and Acute Myocardial Infarction Associated With Stopping Clopidogrel After Acute Coronary Syndrome
Ho et al.
JAMA 2008;299:532-539.
ABSTRACT
| FULL TEXT
Perioperative Stroke
Selim
NEJM 2007;356:706-713.
FULL TEXT
Rebound Inflammation and the Risk of Ischemic Stroke After Discontinuation of Aspirin Therapy--Reply
Maulaz et al.
Arch Neurol 2006;63:301-301.
FULL TEXT
Rebound Inflammation and the Risk of Ischemic Stroke After Discontinuation of Aspirin Therapy
Pijak
Arch Neurol 2006;63:300-301.
FULL TEXT
|
